Dialog Box

Ovarian Cancer Australia in the News View all news

Media Releases

The Hairhouse Foundation is proud to announce its partnership with Ovarian Cancer Australia, launching their round-up purchase program, with additional initiatives to be announced.

Media Releases

Anna Boltong appointed as Chief Executive Officer of Ovarian Cancer Australia

Teal Tribe

Diagnosed with Stage 3 advanced ovarian cancer at the age of 41, Renata shared her story with parliamentary ambassadors at Parliament House.

Media Releases

Pharmaceutical Benefits Advisory Committee (PBAC) has also now recommended the PARP inhibitors Olaparib and Niraparib be listed on the PBS for those with HRD.